TP53 and breast cancer: Using site-specific mutagenesis, ectopic expression of ERs, transactivation assays and ChIP studies with the breast cancer-derived MCF7 cells, the colon cancer-derived HCT116 cells and the HMEC cells, we confirmed that this ERE2 can participate in the cooperative interaction between p53 and ERs.